Developmental conditions may impact the expression of immune traits throughout an individual's life. Early-life challenges may lead to immunological constraints that are mediated by endocrineimmune interactions. In particular, individual differences in the ability to mount immune responses may be programmed by exposure to stressors or glucocorticoid hormones during development.
INTRODUCTION
All living organisms are impacted by microbial pathogens (Hedrick, 2004) . Thus, there is significant selection pressure to minimize the effects of microbial pathogens on survival and reproduction. Despite selection to respond appropriately to these pathogens, individuals exhibit striking variation in immune function. The intrinsic and extrinsic factors that contribute to variation among individuals in immune function have been a central area of research in the field of ecoimmunology since the inception of the field (Martin, Hawley, & Ardia, 2011; Sheldon & Verhulst, 1996) . One explanation for this variation arises from the concept of trade-offs (Sheldon & Verhulst, 1996) . Individuals have limited available resources that must be allocated and traded off among competing demands, which can include immune defense, growth, and reproduction (Sheldon & Verhulst, 1996) . Tradeoffs give rise to individual variation in immune function because the benefits and costs of these competing demands differ among individuals (Sheldon & Verhulst, 1996) . On the basis of life history and environmental conditions, individuals then adaptively modify investment in immune function and exhibit broad flexibility in immune responses (Ardia, Parmentier, & Vogel, 2011) .
The degree of plasticity an individual can express for a given immunological trait, however, is generally limited by a combination of genetic and physiological constraints DeWitt, Sih, & Wilson, 1998) . For example, artificial selection studies have revealed that genetic differences contribute substantially to variation among individuals in immune function (reviewed in Ardia et al., 2011;  Van der Most, de Jong, Parmentier, & Verhulst, 2011) . Physiological state, including energetic reserves, oxidative stress, parasite infection, and age, has also been linked to individual variation in immune function (Folstad & Karter, 1992; Hill, 2011; Koolhaas, 2008; Sheldon & Verhulst, 1996) . Moreover, conditions experienced early in life may influence the epigenetic state and constrain individual variation in immune function that is expressed in adulthood (Macri et al., 2007; Merlot, Couret, & Otten, 2008; Spencer, Martin, Mouihate, & Pittman, 2006) .
One physiological constraint on immune function that has been studied both in adulthood and from a developmental perspective is the complex network of interactions between the hypothalamicpituitary-adrenal (HPA) axis and the immune system. Glucocorticoid hormones produced by the adrenals, such as cortisol and corticosterone, exert profound effects on the immune system. Acute, or shortterm, exposure to glucocorticoids generally stimulates the immune response (Dhabhar & McEwen, 1999; Martin, 2009) , whereas chronic exposure can depress the immune response .
However, the impact of glucocorticoids is also dependent on the type of response measured. For example, glucocorticoids generally stimulate humoral immunity and depress cell-mediated immunity (Bartolomucci, 2007) or cause redistribution of leukocytes out of circulation and into tissues (Dhabhar, Miller, McEwen, & Spencer, 1995) . Exposure to elevated levels of glucocorticoid hormones during development can also exert sustained effects on adult immune function (reviewed in Merlot et al., 2008; Miller, Chen, & Parker, 2011) .
A number of studies have demonstrated that exposure to stressors or exogenous glucocorticoids during early postnatal life can impact immune responses over the short term (e.g., Loiseau, Sorci, Dano, & Chastel, 2008; Saino, Suffritti, Martinelli, & Møller, 2003; Schoech, Rensel, & Heiss, 2011; Stier et al., 2009) . However, few studies have tested for persistent effects of developmental exposure to glucocorticoids or stress on adult immune function, especially in nonmammalian model systems (Schmidt, Kubli, MacDougall-Shackleton, & MacDougall-Shackleton, 2015) . Finally, previous studies have generally not tested for interactions between developmental and adult environmental conditions on adult immune responses (e.g., De Coster et al.,
2011).
To test these ideas, we manipulated exposure to the glucocorticoid hormone corticosterone (CORT) during the nestling and fledgling periods and exposure to the endotoxin lipopolysaccharide (LPS) on days 60 and 100 posthatch in a captive population of zebra finches (Taeniopygia guttata). We utilized a fully crossed design to test for potential interactive effects between the developmental and adult environments (Groothuis & Taborsky, 2015) . We predicted that developmental CORT exposure would have long-term effects on our measures of immune function, and that the ability to respond to a simulated bacterial infection would be impacted by developmental history. We also expected that developmental CORT exposure would lead to increased production of CORT in response to LPS challenge later in life through a programming effect on the HPA axis (sensu Spencer, Evans, & Monaghan, 2009 ).
METHODS

Research animals and housing
Parents of birds used in the study were housed in wire cages (45 cm × 45 cm × 40 cm) in breeding pairs. Independent offspring were housed in larger single sex cages (92 cm × 38 cm × 43 cm) containing 4-10 individuals. Room lighting was maintained on a 13.5L:10.5D light cycle.
All birds were provided with ad libitum access to water, cuttlebone and a blend of red and white millet seeds. Birds were also supplemented once a week with millet spray and a breeding supplement containing dry egg food (ABBA 92A; 
CORT dosing and immune challenges
During the nestling period, young were assigned to either an elevated CORT treatment (N = 74) or the control group (N = 77). Within broods, we attempted to balance the number of young assigned to the CORT and control groups. Between days 12-15 posthatch, birds in the CORT group were orally administered 0.124 mg/mL of CORT in 25 L of peanut oil twice each day (between 9:30 and 10:30 and between 14:30 and 15:30). Between days 16 and 28 posthatch, the CORT-treated birds received an increased dose of 0.163 mg/mL of CORT in 25 L of peanut oil twice each day during the same time periods to account for increased mass ( Fig. 1) (Spencer et al., 2009) . Birds in the control group were given an equal volume of peanut oil throughout the treatment period (Spencer et al., 2009 ).
Once birds reached the age of 60 days posthatch, one-half of the birds in each of the two nestling treatment groups (CORT and control) were challenged with LPS (N = 61) and the other birds were given a control injection (N = 57) (Fig. 1) . Again, we attempted to balance treatment groups within families. LPS-challenged birds were injected with 1.0 mg LPS/kg body weight (Sigma-Aldrich L7261, St. Louis, MO) in 50 L of sterilized phosphate-buffered saline (PBS; Sigma-Aldrich P5368) subcutaneously in the abdomen, and birds in the control group were injected with 50 L of PBS. The immune challenge was repeated on day 100 posthatch (Fig. 1 ).
Blood sample collection for measurement of CORT concentrations
To assess the effectiveness of the experimental manipulation in elevating circulating CORT concentrations, we collected blood samples (50 L from the brachial vein) from all birds on day 14 posthatch, 10 min after administering either CORT or peanut oil only, as appropriate (Khan & Robert, 2013) . On day 60 posthatch, we collected two blood samples (50 L each) from all birds. The first blood sample was collected immediately before administering either the primary LPS immune challenge or an injection of PBS. The second blood sample was collected 1 hr after injection. Blood samples were centrifuged for 7 min at 1,845 × g, plasma was separated from the red blood cells, and samples were stored at -80 • C until analysis. In response to LPS challenge, CORT levels should increase within 1 hr of challenge (Owen-Ashley, Turner, Hahn, & Wingfield, 2006) . The blood samples collected on day 60 allowed us to assess if exposure to elevated levels of CORT during the nestling and fledgling periods affected the responsiveness of the HPA axis to immune challenge.
Quantification of CORT concentrations
We quantified CORT concentrations using an enzyme immunoassay from Enzo Life Sciences (cat. No. ADI-901-097, Farmingdale, NY) and followed the kit instructions. The kit had been validated previously for use with zebra finches (Merrill & Grindstaff, 2015; Wada, Hahn, & Breuner, 2007) . To analyze samples, we diluted them 1:40 in 1% steroid displacement reagent and assay buffer. On each plate, we included a standard curve ranging from 20,000 to 32 pg/mL. Samples were assayed in duplicate and standards were assayed in triplicate. Plates were read on a Biotek ELx808 microplate reader at 405 nm. The assay detection limit is 27 pg (Enzo Life Sciences). The average intra-and interassay coefficients of variation were 6.9% and 22.4%, respectively.
Antibody response to LPS injection
Blood samples (∼50 L) were collected from all birds on days 68 and 108 posthatch to quantify anti-LPS antibody titers in both birds injected with LPS, and those not injected with LPS. Even birds not experimentally exposed to LPS may sometimes have LPS-reactive antibodies due to environmental exposure (Merrill & Grindstaff, 2014) .
Antibody titers were quantified with enzyme-linked immunosorbent assays following previously described methods (Grindstaff, 2008; Grindstaff, Demas, & Ketterson, 2005; Merrill & Grindstaff, 2014) . In brief, plates (Nunc, Maxi-Sorp) were coated with 50 g/mL LPS in carbonate buffer. Plasma samples were diluted 1:40 in 1% milk powder, PBS-Tween 20. The secondary antibody (goat, anti-bird IgG; Bethyl Labs, Montgomery, TX, A140-110P) was diluted to 1:1,000. This antibody may also detect other immunoglobulin isotypes, including IgM (Fassbinder-Orth et al., 2016) . After a 30-min incubation with the substrate buffer, plates were read at 405 nm. Each plate contained a serial dilution of a standard pool that covered the range of antibody titers in samples. Samples and standards were both run in duplicate. The average intra-and interplate coefficients of variation were 7.68% and 13.64%, respectively.
Haptoglobin
On day 100 posthatch, blood samples were collected from all birds both immediately before injection with either PBS or LPS, and 12 hr later to quantify production of the acute phase protein haptoglobin in response to the injection (Hegemann, Matson, Versteegh, Villegas, & Tieleman, 2013) . Subsequently, haptoglobin was quantified with a commercial kit (Tri-Delta Diagnostics, Morris Plains, NJ, TP-801). We diluted plasma samples (5 L) in 20 L of the sample diluent and transferred 7.5 L of diluted samples and standards in duplicate to the plates. We then added 100 L of reagent 1 (hemoglobin). After shaking, plates were read at 630 nm in a plate reader and 140 L of reagent 2, the chromogen, was added. After a 5-min incubation at room temperature, the plate was then read for a second time at 630 nm. The absorbance values from measurements before addition of the chromogen were subtracted from the final absorbance values. The standard curve included haptoglobin concentrations of: 2.5, 1.25, 0.625, 0.313, 0.156, and 0.078 mg/ml. The average intra-and interplate coefficients of variation were 7.08% and 6.32%, respectively.
Bacteria killing ability
We quantified bacteria killing ability (BKA) of the plasma of birds using blood samples collected on days 14, 36, and 60 posthatch. BKA on day 60 was quantified from the sample collected before immune challenge.
BKA methods were derived from Matson, Tieleman, and Klasing (2006) ; Millet, Bennett, Lee, Hau; and Klasing (2007) and Morrison, Ardia, and Clotfelter (2009) . In brief, 5 L of finch plasma was added to a combination of CO 2 -independent media (Gibco, Invitrogen) + 4 mM L-glutamine (90 L) and the Escherichia coli (ATCC #8739, Manassas, VA) bacterial broth (10 L), incubated for 20 min at 40 • C, and then pipetted out in 50 L aliquots onto agar plates. All samples were run in duplicate, and after the solution was evenly distributed across the plates, the plates were then incubated overnight at 37 • C.
Four control plates, containing bacteria but no plasma, were included in each assay. The following day, the number of bacterial colonies were counted and compared to control plates in which the bacterial broth and 95 L of PBS were incubated together without any plasma. Killing ability was calculated by subtracting the mean number of colonies for a bird's two plates from the control mean, and then dividing that by the control mean. Intraassay CV means were 13% for day 14 BKA, 10% for day 36 BKA, and 13% for day 60 BKA.
Statistical analyses
To assess the impact of early-life CORT treatment on circulating CORT concentrations and measures of immune function, we used general linear mixed models (GLMMs). We included CORT treatment (yes or no) as a fixed effect; maternal identity as a random effect; and hatch order, hatch date, sex, and clutch number (i.e., which clutch in the female's life a given nestling originated from) as covariates in initial models for each dependent variable. Covariates that were significant or close to significant (P < 0.06) were retained in the final model. We also examined the association between circulating CORT concentrations on day 14 and BKA on day 36, as well as between CORT concentrations on day 14 and both baseline and LPS-induced CORT concentrations on day 60 to determine if circulating baseline CORT concentrations on day 14 covaried with BKA on day 36, and if CORT concentrations on day 14 were predictive of baseline and/or LPS-induced concentrations on day 60. In addition, we examined associations between baseline CORT concentrations on day 60 and day 36 BKA, day 68 anti-LPS antibody titers, and day 100 baseline haptoglobin and haptoglobin concentrations measured 12 hr after LPS immune challenge on day 100. We ran GLMMs with either day 14 or day 60 baseline CORT concentrations, CORT treatment, the interaction between CORT concentrations and CORT treatment, and any appropriate covariates as fixed effects, maternal identity as a random effect, and the measure of CORT or immune function of interest as the dependent variable. CORT dosing elevated circulating CORT concentrations during the treatment period (i.e., day 14) but did not impact subsequent CORT concentrations, either baseline or concentrations produced in response to lipopolysaccharide (LPS) challenge (LPS CORT). Developmental CORT treatment also did not significantly affect immune parameters. BKA, bacteria killing ability; anti-LPS Ab, specific antibodies to LPS; Hp, haptoglobin; 12-Hr Hp, haptoglobin concentrations measured 12 hr after LPS challenge. Est is the model estimate (slope of the relationship) between parameters. Significant (P < 0.05) effects are given in bold.
TA B L E 1 Effects of developmental treatment with corticosterone (CORT) from days 12 to 28 posthatch on circulating CORT and immune parameters
CORT
To examine the effect of LPS treatment on day 60 CORT concentrations, haptoglobin concentrations, and anti-LPS antibody titers, we ran
GLMMs with LPS treatment (yes or no) as a fixed effect, maternal identity as a random effect, and hatch order, hatch date, sex, clutch number, and the interaction between CORT treatment and LPS treatment as covariates in initial models for each dependent variable. Parameters that were significant or close to significant (P < 0.06) were retained in the final model. For all analyses in which we examined patterns of covariation between physiological parameters, we used only measures for which we had at least 20 individuals in each CORT treatment so as not to draw inferences from small sample sizes. For all analyses, we used maximum likelihood, and the denominator degrees of freedom were approximated using the containment method (Littell, Milliken, Stroup, & Wolfinger K Schabenberger, 2006) . We confirmed normality of residuals and homogeneity of variance, and all analyses were run in SAS 9.4 (Cary, NC). Antibody titer and haptoglobin data were log +1 transformed to achieve normality prior to analysis. Two outliers due to methodological error were removed from analyses, although inclusion of these values did not qualitatively or quantitatively impact results.
Variation in sample sizes for each analysis (see Tables 1-3) reflects changes in the number of individuals due to mortality over time, plasma limitations, and removal of the two outliers.
RESULTS
CORT treatment had a significant effect on baseline CORT concentrations at day 14 (Table 1 , Fig. 2A ), but did not impact any other measure (Table 1 , Fig. 2B ). When we examined the associations between circulating CORT and BKA, we found a negative association between baseline CORT concentrations on day 14 and BKA on day 36 (Table 2) as well as a borderline nonsignificant negative association between baseline CORT concentrations on day 60 and BKA on day 36 (Table 2) . We found no association between baseline CORT concentrations on day 60 and anti-LPS antibody titers measured on day 68 (Table 2) or between baseline CORT concentrations on day 60 and either measure of haptoglobin (Table 2) . We found a strong positive association between baseline CORT concentrations on day 14 and baseline CORT concentrations on day 60 (Table 2 , Fig. 3 ), but no relationship between baseline CORT concentrations on day 14
and LPS-induced CORT concentrations on day 60 (Table 2) . Finally, we found no interaction effects between CORT treatment and circulating CORT concentrations for any measure (Table 2) .
On day 60, birds injected with LPS had significantly higher CORT concentrations 1 hr after injection than control (PBS-injected) birds (Table 3 , Fig. 4A ). There was no effect of LPS treatment on either haptoglobin measure (Fig. 4B ) or day 68 anti-LPS antibody titers (Table 3) , but there was a significant effect of LPS treatment on day 108 anti-LPS antibody titers, in which birds challenged with LPS on days 60 and 100 exhibited a stronger anti-LPS antibody response on day 108 (Table 3 , Fig. 4C ).
DISCUSSION
Based on previous work documenting negative effects of early-life stress on adult measures of immune function and disease resistance in other organisms (reviewed in Martin, 2009; Merlot et al., 2008; Miller et al., 2011) , we anticipated that elevation of CORT levels during the postnatal period would impact the ability of zebra finches to respond to a simulated bacterial challenge on days 60 and 100 posthatch.
However, we did not find evidence for an effect of CORT treatment group during development on subsequent immune responses. CORT concentrations measured during the treatment period were negatively related to BKA measured on day 36, which was eight days after the cessation of the CORT treatment (Fig. 5) . Moreover, there was a nonsignificant negative relationship between baseline CORT concentrations on day 60 and BKA on day 36. These results suggest that elevated baseline CORT levels are negatively associated with BKA in young zebra finches. Second, we predicted that elevation of CORT levels Estimate is the regression coefficient for each predictor and response variable. Bacteria killing ability (BKA) on day 36 was negatively related to CORT concentrations measured on day 14 posthatch. CORT concentrations measured on day 14 were positively related to baseline CORT concentrations measured on day 60 posthatch. Base, baseline; Anti-LPS Ab, specific antibodies to LPS; Clutch number, number of clutches parents had produced; Hp, haptoglobin; 12-Hr Hp, haptoglobin concentrations measured 12 hr after LPS challenge; Trt, treatment. Significant (P < 0.05) effects are in bold. Birds challenged with LPS had significantly higher CORT concentrations 1 hr after challenge than control birds (LPS CORT) and significantly higher LPSspecific antibody titers (Anti-LPS Ab) on day 108 posthatch. LPS challenges were administered on days 60 and 100 posthatch. Hp, haptoglobin; 12-Hr Hp, haptoglobin concentrations measured 12 hr after LPS challenge. Est is the model estimate (slope of the relationship) between parameters. Significant (P < 0.05) effects are in bold.
TA B L E 3 Effect of lipopolysaccharide (LPS) treatment on circulating corticosterone (CORT) and immune parameters
LPS
during the postnatal period would result in increased production of CORT in response to LPS challenge on day 60 through a programming effect on the HPA axis (Spencer et al., 2009) . LPS challenge on day 60 resulted in increased production of CORT 60 min following injection compared to control individuals that were not injected with LPS, but the magnitude of the response was not impacted by developmental CORT treatment (Fig. 5) . In our analyses, we also accounted for the potential effects of hatching date, hatching order and the number of previous clutches produced by the mother. These covariates had significant effects on subsequent immune responses and deserve further F I G U R E 1 Timeline of experimental methods. At 12 days posthatch, young were assigned to either an elevated corticosterone (CORT) treatment group or a control group. Dosing with CORT or the control vehicle continued until day 28 posthatch. On day 14, we collected the first blood sample to quantify corticosterone concentrations and bacteria killing ability. We also measured bacteria killing ability from blood samples collected on days 36 and 60. On days 60 and 100, one-half of the individuals were challenged with lipopolysaccharide (LPS). We collected a blood sample before challenge to measure baseline CORT and a second blood sample one hour after challenge to measure LPS-induced CORT concentrations. We also collected blood samples on days 68 and 108 to quantify LPS-specific antibody (Ab) titers. Finally, on day 100 we collected a blood sample before LPS challenge to quantify baseline haptoglobin (Hp) concentrations and collected a second blood sample 12 hr later to quantify Hp concentrations in response to LPS F I G U R E 2 Effect of treatment with corticosterone (CORT) during the nestling and fledgling periods from days 12-28 posthatch on CORT concentrations during the treatment period (A) and bacteria killing ability after the end of the treatment period (B). CORT treatment significantly elevated CORT concentrations during the treatment period but did not significantly influence bacteria killing ability after the treatment period experimental investigation. Hatching date was negatively related to both BKA on day 14 and haptoglobin concentrations 12 hr after challenge on day 100. Hatching date was positively related to anti-LPS antibody titers on day 108. Hatching order was negatively related to BKA on day 14, although this was largely driven by one nestling that hatched fifth in the brood. Finally, the number of clutches previously produced by the mother was positively related to CORT concentrations produced in response to LPS challenge on day 60 and negatively associated with baseline haptoglobin concentrations on day 100.
Together, our findings provide evidence for dynamic, bidirectional relationships between CORT and measures of immune function, but limited evidence for programming effects of developmental CORT treatment.
The relationship between glucocorticoids and immune function is complex, and depends upon temporal exposure (i.e., acute versus chronic), magnitude of CORT production, and the specific immunological component Martin, 2009; Shini, Huff, Shini, & Kaiser, 2010) . Moreover, the social, demographic, and ecological context can potentially impact relationships between the two.
BKA indicates the potential of the whole blood or plasma to inactivate F I G U R E 3 Relationship between corticosterone (CORT) concentrations during the period of experimental manipulation (day 14) and after the experimental period (day 60). Points are coded by developmental treatment group. Open circles represent birds in the control group and filled circles represent birds in the group with experimentally elevated CORT levels F I G U R E 4 Effect of challenge with lipopolysaccharide (LPS) on corticosterone (CORT) concentrations 1 hr after primary challenge (A), haptoglobin concentrations 12 hr after secondary challenge (B), and anti-LPS antibody titers 8 days after secondary challenge (C). Birds challenged with LPS had significantly higher CORT concentrations and elevated anti-LPS antibody titers relative to control birds, but LPS challenge did not significantly impact haptoglobin concentrations. Diamonds represent birds that received CORT treatment, and circles are those that did not receive CORT F I G U R E 5 Schematic illustration of results. During the nestling and fledgling periods, exposure to corticosterone (CORT) was experimentally manipulated and challenge with lipopolysaccharide (LPS) was experimentally manipulated on days 60 and 100 posthatch. Straight, black arrows represent significant effects of these treatment groups on CORT concentrations and immune parameters. Curved, blue arrows represent significant relationships between traits. Developmental CORT exposure elevated CORT levels during the treatment period (D14 Baseline CORT). Birds challenged with LPS had higher CORT concentrations 1 hr after challenge (D60 LPS CORT) and higher LPS-specific antibody titers on day 108 (D108 anti-LPS Ab). CORT concentrations on day 14 were positively related to baseline CORT concentrations on day 60. CORT concentrations on day 14 were negatively related to bacteria killing ability (BKA) on day 36. Hp, haptoglobin [Color figure can be viewed at wileyonlinelibrary.com] a potential microbial pathogen, and thus is a useful functional measure of the constitutive innate immune response (Boughton, Joop, & Armitage, 2011) . Previous work has indicated that killing for this strain of E. coli (8739) is primarily complement dependent (Matson et al., 2006; Merrill unpublished data) . Complement proteins are an important part of the constitutive innate immune system due to their ability to opsonize or lyse invading microbes (Esser, 1994) . Moreover, they can act as a link between innate and acquired immune defenses by lowering the threshold for B-cell activation and targeting antigen to lymphoid organs (Ochsenbein & Zinkernagel, 2000) . Previous work on BKA with this strain of E. coli indicates that acute stressors typically result in a decrease in BKA (Gao, Sanchez, & Deviche, 2017; Matson et al., 2006; Merrill, Angelier, O'Loghlen, Rothstein, & Wingfield, 2012) . Whether this change in BKA following stress is a product of immunosuppression or immunoredistribution is unclear, but the speed with which these changes can occur (7 min; Merrill et al., 2012) suggests that it may be immunoredistribution of immunological components in preparation for coping with an impending injury and associated influx of microbes (sensu Dhabhar, 2009; Martin, 2009 ).
The results from the present study are distinct from the ones described above, however, because the negative association we measured was between baseline CORT and BKA. Merrill, Levinson, O'Loghlen, Wingfield, and Rothstein (2014) found a significant positive association between baseline CORT and BKA in wild male red-winged blackbirds (Agelaius phoeniceus) during the breeding season, and
Merrill, Gonzalez-Gomez, Ellis, Levin, Vasquez, and Wingfield (2015) found that the direction of the relationship between baseline CORT and BKA differed by month in rufous-collared sparrows (Zonotrichia capensis). The work on rufous-collared sparrows indicates that the association between baseline CORT and BKA may be impacted by other factors such as life-history stage. Finally, in work examining baseline CORT and BKA in molting brown-headed cowbirds (Molothrus ater), Ellis, Merrill, Wingfield, O'Loghlen, and Rothstein (2012) found a negative association between the two measures in female cowbirds during molt, although they found no association between the two parameters prior to, or following, molt. The negative relationships between baseline CORT and BKA in young zebra finches could potentially reflect CORT-mediated downregulation of BKA to reduce oxidative stress (sensu Dhabhar, 2009) , or an investment strategy to free resources for other processes such as somatic growth or feather development. These nonmutually exclusive theories would require explicit testing. Additionally, one important difference between the prior studies and the current study is that these prior studies were all conducted in wild birds, whereas we studied zebra finches in captivity. The lower BKA in association with increased baseline CORT is unlikely to solely be a product of immunoredistribution because immunoredistribution is generally a short-term response to an acute stressor .
We found no effect of LPS treatment on specific anti-LPS antibody production on day 68, but there was a significant effect of LPS treatment on anti-LPS antibody production on day 108 (Fig. 5) . This difference likely reflects that the challenge on day 60 was a primary exposure for the birds and primary antibody responses are characterized by slower, weaker antibody responses, primarily of the IgM isotype (Janeway, Travers, Walport, & Shlomchik, 2001 ). Thus, if we had collected blood samples at a later time point after the primary immune challenge on day 60 or had been able to more specifically quantify IgM, we might have detected an effect of LPS treatment on antibody titers. However, we did not find evidence at either time point that developmental CORT treatment affected the ability of birds to respond to LPS challenge by producing antibodies. This does not support the hypothesis that systemically elevated CORT levels can program immune responses (Taves, Hamden, & Soma, 2017) .
Contrary to our predictions, we found no effect of either CORT or LPS exposure on haptoglobin production. Data from other species suggest that haptoglobin levels may increase, decrease, or remain the same after LPS challenge (Bailly et al., 2016; Hegemann et al., 2013; Millet et al., 2007; Schultz, Hahn, & Klasing, 2017; Zylberberg, 2015) .
The haptoglobin response to LPS challenge has been demonstrated to vary among closely related species (Zylberberg, 2015) , to vary across populations within a species (Bailly et al., 2016) , and to vary seasonally within a species (Hegemann et al., 2013) . Thus, it is difficult to generalize and describe the typical avian haptoglobin response to LPS challenge. Although there is some evidence that acute stressors can influence haptoglobin levels (e.g., Zylberberg, 2015) , previous studies have not assessed the potential for CORT exposure during the nestling and fledgling periods to have a persistent effect on haptoglobin production.
During the acute phase response to immune challenge, activation of the HPA axis occurs, resulting in elevated levels of glucocorticoids (Bateman, Singh, Kral, & Solomon, 1989; Besedovsky & del Rey, 1996; Owen-Ashley et al., 2006; Owen-Ashley & Wingfield, 2007 ). Spencer et al. (2009 used the same protocol for chronic exposure to CORT in zebra finches that we used in the current study, but in contrast to our findings, they documented programming effects of CORT exposure on the HPA axis. Birds exposed to elevated levels of CORT during the nestling and fledgling periods produced elevated levels of CORT in response to restraint stress at 60 days posthatch (Spencer et al., 2009 ).
In the current study, zebra finches produced a robust CORT response to LPS challenge on day 60, but we did not find evidence that the magnitude of this response was programmed by chronic exposure to CORT during development.
Although we found no effect of CORT treatment on day 60 baseline or LPS-induced CORT concentrations, we did find a positive relationship between baseline CORT concentrations during the treatment period (day 14) and baseline CORT concentrations on day 60
( to levels in plasma and relative to levels of CORT at day 30 posthatch (Schmidt & Soma, 2008) . Additionally, cortisol levels are higher in the thymus than in the blood during this period (Schmidt & Soma, 2008; Taves et al., 2016) . Targeted Third, chronic exogenous CORT treatment may initially elevate CORT levels as we observed on day 14, but may not result in sustained elevation of CORT levels due to negative feedback regulation (Romero, 2004; Young, Kwak, & Kottak, 1995) . This emphasizes an additional weakness of utilizing exogenous CORT administration to experimentally mimic chronic stress exposure.
In humans, early-life stressors are associated with immune dysregulation later in life (reviewed in Fagundes, Glaser, & Kiecolt-Glaser, 2013) . Acute inflammatory responses provide important protection against pathogens during the early stages of an immune response.
However, downregulation is necessary to suppress the inflammatory response and prevent development of a chronic inflammatory state.
One important negative feedback mechanism used to downregulate the immune response is the release of glucocorticoids, which bind to receptors on immune cells such as macrophages and suppress further release of inflammatory cytokines (reviewed in Martin, 2009; Miller et al., 2011) . It has been proposed that early-life stress programs macrophages both to release greater levels of pro-inflammatory cytokines in response to immune challenge and to be less sensitive to downregulation by glucocorticoids (Miller et al., 2011) . Thus, early-life stress becomes associated with a chronic inflammatory state (Miller et al., 2011) . If the predominant glucocorticoid released systemically in response to stress in zebra finches is corticosterone, but the glucocorticoid responsible for programming effects on the immune response is cortisol (Taves et al., 2017) , then this may protect zebra finches from any effects of chronic stress during development on the immune response, particularly the adaptive immune response.
CONCLUSIONS
We found no long-term programming effects of repeated CORT exposure during the nestling and fledgling periods on immune function or HPA axis activity. However, cortisol, rather than corticosterone, may 
